Skip to main content
. 2019 Jun 13;11(1):142–150. doi: 10.1111/jdi.13075

Figure 5.

Figure 5

Change in fasting blood glucose (FBG) from baseline to week 26 in Chinese patients with type 2 diabetes who were treated with dulaglutide 1.5 mg, dulaglutide 0.75 mg or glimepiride. Difference in least‐squares mean (LSM; 95% confidence interval) between dulaglutide 1.5 mg and glimepiride. Difference in LSM (95% confidence interval) between dulaglutide 0.75 mg and glimepiride. *P < 0.05 versus glimepiride; ***P < 0.001 versus glimepiride. SE, standard error.